134 related articles for article (PubMed ID: 38457911)
1. Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
Hu X; Li E; Zhou Y; You Q; Jiang Z
Bioorg Med Chem; 2024 Mar; 102():117677. PubMed ID: 38457911
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Liu Q; Zhou H; Langdon WY; Zhang J
Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
[TBL] [Abstract][Full Text] [Related]
3. Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b).
Zhou L; Yang J; Zhang K; Wang T; Jiang S; Zhang X
J Med Chem; 2024 Jan; 67(2):816-837. PubMed ID: 38181380
[TBL] [Abstract][Full Text] [Related]
4. Targeting Cbl-b in cancer immunotherapy.
Augustin RC; Bao R; Luke JJ
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750253
[TBL] [Abstract][Full Text] [Related]
5. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
6. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S; Penninger JM
Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
[TBL] [Abstract][Full Text] [Related]
7. Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors.
Mfuh AM; Boerth JA; Bommakanti G; Chan C; Chinn AJ; Code E; Fricke PJ; Giblin KA; Gohlke A; Hansel C; Hariparsad N; Hughes SJ; Jin M; Kantae V; Kavanagh SL; Lamb ML; Lane J; Moore R; Puri T; Quinn TR; Reddy I; Robb GR; Robbins KJ; Gancedo Rodrigo M; Schimpl M; Singh B; Singh M; Tang H; Thomson C; Walsh JJ; Ware J; Watson IDG; Ye MW; Wrigley GL; Zhang AX; Zhang Y; Grimster NP
J Med Chem; 2024 Jan; 67(2):1500-1512. PubMed ID: 38227216
[TBL] [Abstract][Full Text] [Related]
8. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
[TBL] [Abstract][Full Text] [Related]
9. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes.
Veselits M; Tanaka A; Lipkowitz S; O'Neill S; Sciammas R; Finnegan A; Zhang J; Clark MR
PLoS One; 2014; 9(3):e89792. PubMed ID: 24651487
[TBL] [Abstract][Full Text] [Related]
10. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
[TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.
Jafari D; Mousavi MJ; Keshavarz Shahbaz S; Jafarzadeh L; Tahmasebi S; Spoor J; Esmaeilzadeh A
Clin Exp Immunol; 2021 Apr; 204(1):14-31. PubMed ID: 33306199
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation.
Yang WX; Jin R; Jiang CM; Wang XH; Shu J; Li L; Zhu LH; Zhuang LL; Gao C; Zhou GP
FEBS Lett; 2015 Jul; 589(15):1975-80. PubMed ID: 26112603
[TBL] [Abstract][Full Text] [Related]
14. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
[TBL] [Abstract][Full Text] [Related]
15. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin E3 ligase Cbl-b in T cells tolerance and tumor immunity.
Loeser S; Penninger JM
Cell Cycle; 2007 Oct; 6(20):2478-85. PubMed ID: 17704644
[TBL] [Abstract][Full Text] [Related]
18. Cbl-b modulated TrkA ubiquitination and function in the dorsal root ganglion of mice.
Chen HK; Li YZ; Ge AN; Zhu YB; Wu SJ; Bai X; Bai HH; Liu YN
Eur J Pharmacol; 2022 Apr; 921():174876. PubMed ID: 35288194
[TBL] [Abstract][Full Text] [Related]
19. Regulation of immune responses by E3 ubiquitin ligase Cbl-b.
Tang R; Langdon WY; Zhang J
Cell Immunol; 2019 Jun; 340():103878. PubMed ID: 30442330
[TBL] [Abstract][Full Text] [Related]
20. T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation.
Vos WG; van Os BW; den Toom M; Beckers L; van Roomen CPAA; van Tiel CM; Mohapatra BC; Band H; Nitz K; Weber C; Atzler D; de Winther MPJ; Bosmans LA; Lutgens E; Seijkens TTP
Front Immunol; 2024; 15():1297893. PubMed ID: 38504977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
